APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 29 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,938,921 | +38.9% | 39,528,000 | +163.5% | 2.17% | +52.9% |
| Q2 2023 | $35,954,355 | +38.8% | 15,000,000 | -14.5% | 1.42% | +37.4% |
| Q2 2022 | $25,898,000 | -40.6% | 17,550,000 | -36.3% | 1.03% | -23.8% |
| Q1 2022 | $43,604,000 | +44.9% | 27,550,000 | +37.2% | 1.36% | +45.1% |
| Q4 2021 | $30,085,000 | +62.4% | 20,079,000 | +33.2% | 0.94% | +69.1% |
| Q3 2021 | $18,525,000 | -22.1% | 15,079,000 | +18.3% | 0.55% | -22.3% |
| Q2 2021 | $23,782,000 | +382.1% | 12,750,000 | +183.3% | 0.71% | +328.9% |
| Q3 2020 | $4,933,000 | – | 4,500,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 39,528,000 | $49,938,921 | 2.17% |
| LINDEN ADVISORS LP | 15,000,000 | $18,816,676 | 0.19% |
| Verition Fund Management LLC | 12,454 | $15,645,338 | 0.18% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,766,000 | $14,863,606 | 0.17% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,017,000 | $1,284,573 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 12,242,000 | $15,379 | 0.02% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 300,000 | $371,070 | 0.01% |
| D. E. Shaw & Co., Inc. | 5,000,000 | $6,267,238 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 504,000 | $623,398 | 0.00% |